LOS ANGELES, Jan. 02, 2018 -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (JLT), the leading global specialist risk advisor and broker, is pleased to announce the appointment Art Morgenstein as Senior Vice President.
Based in Los Angeles, Art Morgenstein will be primarily responsible for client servicing and growth initiatives in the West, taking advantage of JLT’s industry and product specialties.
Art brings to JLT over 38 years of insurance industry experience and has held a number of senior leadership, underwriting and account executive positions at various international brokerage firms and insurance carriers. He joins JLT from Aon plc, where he served as Senior Vice President. Within this role, he focused on global and enterprise risk management with expertise in the areas of risk financing, assessment, and in the design and implementation of property, casualty, professional liability programs for complex risks in the retail, hospitality, private equity, manufacturing, technology, real estate and healthcare industries.
“We are delighted that Art has joined JLT. His experience will be invaluable to our clients and our team throughout the U.S.,” said Mike Rice, CEO at JLT Specialty USA. “Art’s appointment is a reflection of our on-going commitment to hire the best talent available in our industry.”
Art is an honor’s graduate from the State University of New York at Stony Brook with a B.S. in Biology and a Masters of Business Administration in Finance from Pepperdine University.
He is a Certified Insurance Counselor and an active member of the Independent Insurance Agents and Brokers of California and Risk and Insurance Management Society.
JLT encourages any potential applicants interested in rapidly developing their careers and becoming part of its U.S. Specialty team to contact Karen Isaacs at 215-309-4601, [email protected].
JLT ENQUIRIES:
Name: Ashely Deal, VP of Marketing
Phone: (310) 266-9464
Email: [email protected]
NOTES TO EDITORS:
About Jardine Lloyd Thompson (JLT.L)
Jardine Lloyd Thompson is one of the world’s leading providers of insurance, reinsurance and employee benefits related advice, brokerage and associated services. JLT’s client proposition is built upon its deep specialist knowledge, client advocacy, tailored advice and service excellence.
JLT is quoted on the London Stock Exchange and owns offices in 40 territories with more than 10,600 employees. Supported by the JLT International Network, it offers risk management and employee benefit solutions in 135 countries.
For further information about JLT, please visit our website www.jlt.com and follow us on LinkedIn at JLT Group and Twitter @JLTGroup.
About JLT Specialty USA
JLT Specialty USA is the U.S. platform of the leading specialty business advisory firm, Jardine Lloyd Thompson Group. Our experts have deep industry and product experience serving leading U.S. and global firms. Our key to client success is our freedom to be creative, collaborative, and analytical while challenging conventions, redefining problems, creating new analytical insights, and exploring new boundaries to deliver solutions for each client’s unique business and risks.
For further information about JLT, please visit our website www.jltus.com and follow us on LinkedIn at JLT Specialty USA and Twitter @JLTSpecialtyUSA.


Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
How Marco Pharma International Preserves German Homeopathic Traditions in America
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 



